# reload+after+2024-01-20 11:45:00.707690
address1§3100 Hanover Street
city§Palo Alto
state§CA
zip§94304
country§United States
phone§855 698 8887
fax§888 974 4258
website§https://guardanthealth.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360; Guardant360 LDT; Guardant360 CDx; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, a suite of advanced analytical technologies to enhance the performance and clinical utility of cancer tests. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. has a research collaboration agreement with the Parker Institute for Cancer Immunotherapy to study the correlation between molecular cancer biomarkers and patient response to immunotherapy treatment across various types of cancer. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
fullTimeEmployees§1793
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Helmy  Eltoukhy Ph.D.', 'age': 44, 'title': 'Co-Founder, Co-CEO & Chairman', 'yearBorn': 1979, 'fiscalYear': 2022, 'totalPay': 11632, 'exercisedValue': 0, 'unexercisedValue': 16381308}, {'maxAge': 1, 'name': 'Dr. AmirAli  Talasaz Ph.D.', 'age': 44, 'title': 'Co-CEO & Director', 'yearBorn': 1979, 'fiscalYear': 2022, 'totalPay': 11175, 'exercisedValue': 0, 'unexercisedValue': 13067510}, {'maxAge': 1, 'name': 'Mr. Michael  Bell', 'age': 54, 'title': 'Chief Financial Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 630994, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John G. Saia', 'age': 50, 'title': 'Chief Legal Officer & Corporate Secretary', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 627184, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Craig  Eagle M.D.', 'age': 56, 'title': 'Chief Medical Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 649135, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christopher  Freeman', 'age': 49, 'title': 'Chief Commercial Officer', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 630393, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Darya  Chudova', 'title': 'Chief Technology Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kumud  Kalia', 'age': 57, 'title': 'Chief Information Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jennifer  Higgins', 'title': 'Vice President of Public Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Terilyn Juarez Monroe', 'age': 56, 'title': 'Chief People Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§1
boardRisk§7
compensationRisk§9
shareHolderRightsRisk§8
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.985
priceToSalesTrailing12Months§5.8403587
currency§USD
dateShortInterest§1702598400
forwardEps§-3.38
pegRatio§0.37
exchange§NMS
quoteType§EQUITY
shortName§Guardant Health, Inc.
longName§Guardant Health, Inc.
firstTradeDateEpochUtc§1538659800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§6848ae6f-8e78-3062-b1b2-3476c9ecd258
gmtOffSetMilliseconds§-18000000
targetHighPrice§64.0
targetLowPrice§27.0
targetMeanPrice§46.56
targetMedianPrice§46.0
recommendationMean§1.8
recommendationKey§buy
numberOfAnalystOpinions§18
quickRatio§5.485
grossMargins§0.60495996
ebitdaMargins§-0.88882005
trailingPegRatio§None
